Overview of Dr. Oved
Joseph Oved, MD, is a pediatric hematology and oncology specialist based in New York, NY. He graduated from the New York University School of Medicine in 2013 and completed his pediatrics residency at New York Presbyterian Hospital (Cornell Campus) in 2016. Dr. Oved is experienced in transplantation for non-malignant disorders and in particular inborn errors of immunity and bone marrow failure syndromes. A second focus of his work involves reducing toxicities from hematopoietic cell transplantation and specifically trying to develop non-chemotherapeutic agents for conditioning regimens. He has written several innovative multi-center clinical trials in these areas and his research has been featured in reputed journals such as The Lancet and Cell Stem Cell.
Office
1275 York Avenue
New York, NY 10065
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2013 - 2016
- New York University School of MedicineClass of 2013
Certifications & Licensure
- FL State Medical License 2022 - Present
- NJ State Medical License 2021 - 2025
- NY State Medical License 2018 - 2025
- PA State Medical License 2016 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Successful hematopoietic cell transplantation utilizing myeloablative reduced-toxicity conditioning in Chediak-Higashi syndrome.Alan Bidgoli, Binni Kunvarjee, Andromachi Scaradavou, Richard J O'Reilly, Jaap Jan Boelens
The Journal of Allergy and Clinical Immunology. 2025-02-01 - A semiautomated microfluidic ELISA for the detection of hemophagocytic lymphohistiocytosis biomarkers.Adrianna Zara Herskovits, William T Johnson, Joseph H Oved, Spencer Irwin, Sital Doddi
American Journal of Clinical Pathology. 2025-01-28 - 1 citationsThe role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell e...Joseph H Oved, Athena Russell, Amy DeZern, Susan E Prockop, Carmem Bonfim
Cytotherapy. 2025-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: